SS
Sudha Shrivastav
About Sudha Shrivastav
Data last updated:
Sudha Shrivastav is a Director at Nkb Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Nkb Pharmaceuticals Private Limited reported revenue of ₹25,753 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nkb Pharmaceuticals Private Limited U47721UP2023PTC183002 | Director | 30 May 2023 | 2023 | ₹25,753 (FY 2025) | Active |
Board colleagues of Sudha Shrivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Singh | 10182270 | Nkb Pharmaceuticals Private Limited | Director |
| Needhi Singh | 10182267 | Nkb Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudha Shrivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudha Shrivastav
Sudha Shrivastav currently holds 1 directorship: Nkb Pharmaceuticals Private Limited (Director, since 30 May 2023, revenue ₹25,753 (FY 2025)).
Sudha Shrivastav was first appointed on 30 May 2023 as Director at Nkb Pharmaceuticals Private Limited.
The current boards of Sudha Shrivastav's companies include Manish Singh (Nkb Pharmaceuticals Private Limited), Needhi Singh (Nkb Pharmaceuticals Private Limited).